Evidence map›Paper›PMID 38171504›Full record

ArticleJournal of clinical neurology (Seoul, Korea)2024

Accumulation Area of a Japanese

Kohei Suzuyama, Makoto Eriguchi, Hiromu Minagawa, Hiroyuki Honda, Keita Kai, Tetsuyuki Kitamoto, Hideo Hara

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical neurology (Seoul, Korea), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kohei SuzuyamaDivision of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine, Saga, Japan. sj8817@cc.saga-u.ac.jp.ORCID https://orcid.org/0000-0002-6077-0758
Makoto EriguchiDivision of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine, Saga, Japan.ORCID https://orcid.org/0000-0002-8275-2331
Hiromu MinagawaDivision of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine, Saga, Japan.
Hiroyuki HondaDepartment of Neuropathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.ORCID https://orcid.org/0000-0002-4225-7248
Keita KaiDepartment of Pathology, Saga University Hospital, Saga, Japan.ORCID https://orcid.org/0000-0003-1553-2598
Tetsuyuki KitamotoDepartment of Neurological Science, Tohoku University Graduate School of Medicine, Sendai, Japan.ORCID https://orcid.org/0000-0002-6298-2439
Hideo HaraDivision of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine, Saga, Japan.ORCID https://orcid.org/0000-0003-3289-3555

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe coast of Kyushu Island on Ariake Sea in Japan is known to be an accumulation area for patients with a proline-to-leucine substitution mutation at residue 102 (P102L) of the human prion protein gene (

methodsWe enrolled patients with the

resultsWe enrolled 24 patients from 19 family lines, including 12 males. The mean age at symptom onset was 60.6 years (range, 41-77 years). The incidence rate of the Ariake

conclusionsThis is the first report of the accumulation area of a

Indexed as

genetic prionGerstmann–Sträussler–Scheinker diseaseP102L

Identifiers

PMID38171504
PMCPMC11076189

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.